The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
出版年份 2013 全文链接
标题
The Future of Thiazolidinedione Therapy in the Management of Type 2 Diabetes Mellitus
作者
关键词
Thiazolidinedione, Peroxisomal proliferator-activated receptor-γ, Pioglitazone, Rosiglitazone, Type 2 diabetes mellitus, Insulin resistance, Dyslipidemia, Nonalcoholic fatty liver disease, Nonalcoholic steatoh epatitis, Polycystic ovarian syndrome
出版物
Current Diabetes Reports
Volume 13, Issue 3, Pages 329-341
出版商
Springer Nature
发表日期
2013-05-01
DOI
10.1007/s11892-013-0378-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control: The Rotterdam Study
- (2013) L. Oei et al. DIABETES CARE
- Is There a Role for Laparoscopic Adrenalectomy in Patients with Suspected Adrenocortical Carcinoma? A Critical Appraisal of the Literature
- (2013) C. Jurowich et al. HORMONE AND METABOLIC RESEARCH
- Pioglitazone Slows Progression of Atherosclerosis in Prediabetes Independent of Changes in Cardiovascular Risk Factors
- (2012) Aramesh Saremi et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Rosiglitazone Inhibits Bone Regeneration and Causes Significant Accumulation of Fat at Sites of New Bone Formation
- (2012) Lichu Liu et al. CALCIFIED TISSUE INTERNATIONAL
- Risk of Fracture with Thiazolidinediones: Disease or Drugs?
- (2012) Marloes T. Bazelier et al. CALCIFIED TISSUE INTERNATIONAL
- A phase 1 study of efatutazone, an oral peroxisome proliferator-activated receptor gamma agonist, administered to patients with advanced malignancies
- (2012) Michael J. Pishvaian et al. CANCER
- Features, Diagnosis, and Treatment of Nonalcoholic Fatty Liver Disease
- (2012) Dawn M. Torres et al. Clinical Gastroenterology and Hepatology
- Pioglitazone Prevents Smoking Carcinogen-Induced Lung Tumor Development in Mice
- (2012) M. -Y. Li et al. CURRENT CANCER DRUG TARGETS
- A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome
- (2012) Qiang Du et al. CURRENT MEDICAL RESEARCH AND OPINION
- Thiazolidinedione use and cancer incidence in type 2 diabetes: A systematic review and meta-analysis
- (2012) I.N. Colmers et al. DIABETES & METABOLISM
- Use of thiazolidinedione and cancer risk in Type 2 diabetes: The Hong Kong diabetes registry
- (2012) Xilin Yang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study
- (2012) A. Neumann et al. DIABETOLOGIA
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
- (2012) H. M. Colhoun et al. DIABETOLOGIA
- Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
- (2012) Kenneth Cusi GASTROENTEROLOGY
- Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism
- (2012) Aleksandra Mieczkowska et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pioglitazone and bladder cancer in human studies: Is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?
- (2012) Chin-Hsiao Tseng JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION
- Association Between Longer Therapy With Thiazolidinediones and Risk of Bladder Cancer: A Cohort Study
- (2012) Ronac Mamtani et al. JNCI-Journal of the National Cancer Institute
- Use of thiazolidinediones and risk of osteoporotic fracture: disease or drugs?
- (2012) Marloes T. Bazelier et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes
- (2012) George R. Beck et al. Translational Research
- The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone
- (2012) Sun Ok Song et al. Diabetes & Metabolism Journal
- Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus
- (2011) Adrian V. Hernandez et al. American Journal of Cardiovascular Drugs
- Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
- (2011) Shih-Wei Lai et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
- (2011) X.- X. He et al. ANNALS OF ONCOLOGY
- Cell death is induced by ciglitazone, a peroxisome proliferator-activated receptor γ (PPARγ) agonist, independently of PPARγ in human glioma cells
- (2011) Myoung Woo Lee et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pioglitazone and Bladder Cancer: A population-based study of Taiwanese
- (2011) C.-H. Tseng DIABETES CARE
- Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone: Interim report of a longitudinal cohort study
- (2011) J. D. Lewis et al. DIABETES CARE
- Efficacy and safety of the PPARγ partial agonist balaglitazone compared with pioglitazone and placebo: a phase III, randomized, parallel-group study in patients with type 2 diabetes on stable insulin therapy
- (2011) Kim Henriksen et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan
- (2011) C.-H. Tseng DIABETOLOGIA
- Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
- (2011) Romina Lomonaco et al. HEPATOLOGY
- Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
- (2011) Chia-Hsuin Chang et al. HEPATOLOGY
- Pioglitazone, etoricoxib, interferon-α, and metronomic capecitabine for metastatic renal cell carcinoma: final results of a prospective phase II trial
- (2011) B. Walter et al. MEDICAL ONCOLOGY
- Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
- (2011) Ralph A. DeFronzo et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Antidiabetic Drug Ciglitazone Induces High Grade Bladder Cancer Cells Apoptosis through the Up-Regulation of TRAIL
- (2011) Marie-Laure Plissonnier et al. PLoS One
- Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
- (2011) Maria Vinaixa et al. PLoS One
- Metformin vs thiazolidinediones for treatment of clinical, hormonal and metabolic characteristics of polycystic ovary syndrome: a meta-analysis
- (2010) X-J. Li et al. CLINICAL ENDOCRINOLOGY
- Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- (2010) R. E. Aubert et al. DIABETES OBESITY & METABOLISM
- Effects of the peroxisome proliferator-activated receptor (PPAR)-γ agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals
- (2010) A. Zanchi et al. DIABETOLOGIA
- Effect of the insulin sensitizers metformin and pioglitazone on endothelial function in young women with polycystic ovary syndrome: a prospective randomized study
- (2010) Katerina K. Naka et al. FERTILITY AND STERILITY
- Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months
- (2010) Lourdes Ibáñez et al. GYNECOLOGICAL ENDOCRINOLOGY
- Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues
- (2010) Vlad Ratziu et al. HEPATOLOGY
- Effects of high dose aleglitazar on renal function in patients with type 2 diabetes
- (2010) Matthias Herz et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Pioglitazone Use in Combination with Insulin in the Prospective Pioglitazone Clinical Trial in Macrovascular Events Study (PROactive19)
- (2010) Bernard Charbonnel et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinediones and Fractures: Evidence from Translating Research into Action for Diabetes
- (2010) Dori Bilik et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Thiazolidinedione Use and the Longitudinal Risk of Fractures in Patients with Type 2 Diabetes Mellitus
- (2010) Zeina A. Habib et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
- (2010) Arun J. Sanyal et al. NEW ENGLAND JOURNAL OF MEDICINE
- A prospective randomized trial comparing the clinical and endocrinological outcome with rosiglitazone versus laparoscopic ovarian drilling in patients with polycystic ovarian disease resistant to ovulation induction with clomiphene citrate
- (2009) K. K. Roy et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Successful switch from insulin therapy to treatment with pioglitazone in type 2 diabetes patients with residual β-cell function: results from the PioSwitch Study
- (2009) C. Hohberg et al. DIABETES OBESITY & METABOLISM
- The association between thiazolidinediones and hospitalisation for fracture in type 2 diabetic patients: a Taiwanese population-based nested case–control study
- (2009) F.-Y. Hsiao et al. DIABETOLOGIA
- Safety and Tolerability of Pioglitazone in High-Risk Patients with Type 2 Diabetes
- (2009) John Dormandy et al. DRUG SAFETY
- Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial
- (2009) Vlad Ratziu et al. HEPATOLOGY
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- (2009) OBSTETRICS AND GYNECOLOGY
- Fat and Beyond: The Diverse Biology of PPARγ
- (2008) Peter Tontonoz et al. Annual Review of Biochemistry
- Rapid improvement of carotid plaque echogenicity within 1 month of pioglitazone treatment in patients with acute coronary syndrome
- (2008) Mitsumasa Hirano et al. ATHEROSCLEROSIS
- Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone
- (2008) Issa J Dahabreh Clinical Trials
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
- (2008) Vlad Ratziu et al. GASTROENTEROLOGY
- Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis
- (2008) Guruprasad P. Aithal et al. GASTROENTEROLOGY
- Switch to oral hypoglycemic agent therapy from insulin injection in patients with type 2 diabetes
- (2008) Takashi Okamoto et al. Geriatrics & Gerontology International
- Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
- (2008) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
- (2008) Vanita R. Aroda et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin for the Treatment of the Polycystic Ovary Syndrome
- (2008) John E. Nestler NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search